Patterns of renal angiomyolipoma regression post embolisation on medium- to long-term follow-up

ArticleinThe British journal of radiology 86(1024) · February 2013with24 Reads
DOI: 10.1259/bjr.20120633 · Source: PubMed
Abstract
Objective: To assess the patterns of regression of renal angiomyolipoma (AML) post embolisation and report the outcomes related to the use of different embolic materials. Methods: A retrospective review of all patients who underwent embolisation for renal AML at our institution between January 2004 and April 2012. Results: 13 patients underwent 16 episodes of embolisation. Coils were used as the primary embolisation material in 10 episodes and microspheres in 6 episodes. The size reduction rate highly correlated on CT follow-up between the two groups, with 25.6% vs 22.7% reduction at 12 months, 27.5% vs 25.1% at 24 months, 35.0% vs 33.0% at 36 months and 35.0% vs 36.8% at 48 months. During follow-up, all tumours reduced in size with one patient requiring subsequent embolisation whose tumour reduced by only 6.5% after 1 year and subsequently exhibited regrowth after 4 years. Two patients presented with rebleeding and underwent repeat embolisation. Our overall retreatment rate (23%) is well within the literature range (up to 37%). None of the patients underwent surgery. Conclusion: The majority of AML shrinkage occurs within the first year following emboli-sation and appears to plateau after 3 years, which could have an impact on follow-up strategy. The percentage reduction at 1 year may reflect the long-term effect of embolisation with tumours demonstrating minor size reduction more likely to relapse at long-term follow-up. Embolisation of renal AML produces durable long-term results regardless of the choice of embolic agent. Advances in knowledge: These findings provide information to guide CT follow-up of renal AML post embolisation.
    • "Indeed we studied a heterogeneous population of sporadic AML (n=12) and TS patient (n=7). The follow-up was variable; median was 28 months (21–37) (range 12–50) but we do not think it is a major limitation because the majority of AML shrinkage occurs within the first year following embolization [20]. We used a variable combination of embolization agents and this results in a highly variable combination of techniques. "
    [Show abstract] [Hide abstract] ABSTRACT: To evaluate the efficacy of selective arterial embolization (SAE) of angiomyolipomas based on the percentage volume reduction after embolization and to identify predictive factors of volume decrease. Patients receiving prophylactic SAE of renal angiomyolipomas were included retrospectively over 3 years. The volume change after SAE and haemorrhagic or surgical events were recorded. Initial tumour volume, percentage tumour fat content, mean tumour density, embolic agent used, number of angiomyolipomas and tuberous sclerosis disease were evaluated as predictive factors of volume decrease. A total of 19 patients with 39 angiomyolipomas were included with median follow-up of 28 months (interquartile range 21-37 months). All treatments were technically successful (92 % primary and 8 % secondary). No distal bleeding or any increase in size or surgical nephrectomy after SAE was recorded. Mean volume reduction was 72 % (+/- 24 %). Volumes before SAE (R (2) = 0.276; p = 0.001), percentage fat content (R (2) = 0.612; p < 0.0001) and mean angiomyolipoma density (R (2) = 0.536; p < 0.0001) were identified as predictive factors of volume decrease. In multivariate regression, only percentage fat content influenced volume decreases. SAE is an efficient treatment for angiomyolipoma devascularisation and volume reduction. A significant reduction of volume is modulated by the initial volume and tissue composition of the tumour. aEuro cent Selective arterial embolization is effective for angiomyolipoma devascularisation and volume reduction aEuro cent Volume reduction depends of initial volume and tissue composition of the tumour aEuro cent Selective arterial embolization is a low radiation treatment.
    Full-text · Article · Jun 2014
  • [Show abstract] [Hide abstract] ABSTRACT: Although Wilms tumor is the most common renal malignancy in children, the differential diagnosis is extensive and includes both malignant and benign disorders. We present a simple mnemonic-WARM N COLD, to aid in remembering these diverse tumors. Imaging clues including age of the patient, associated disease or syndrome as well as salient imaging characteristics such as bilaterality, and type or presence of metastasis are also presented and can help differentiate between these renal tumors of childhood.
    Article · Feb 2014
  • [Show abstract] [Hide abstract] ABSTRACT: Renal arterial embolization (RAE) performed for the treatment of renal masses has been proven to be a safe and effective technique, with several decades of experience. RAE is well tolerated with few complications, particularly if the time interval from embolization to surgery is reduced to less than 48 hours. Review of the literature suggests that RAE is also extremely effective for palliation of symptoms in the setting of nonoperative advanced stage renal cell carcinoma. In addition, this technique plays a large role in the management of angiomyolipomas that are symptomatic or at risk of spontaneous rupture. To date, RAE has not been evaluated in a randomized controlled setting, which has contributed to its underutilization. All of these potential benefits warrant the need for prospective studies for further validation.
    Article · Mar 2014
Show more

    Recommended publications

    Discover more